Delhi HC scraps government ban on 344 fixed dose combination drugs | Latest News India - Hindustan Times
close_game
close_game

Delhi HC scraps government ban on 344 fixed dose combination drugs

Hindustan Times | ByRocky Soibam Singh, New Delhi
Dec 01, 2016 12:48 PM IST

Popular drugs such as Benadryl may soon be back on shop shelves after the Delhi high court scrapped on Thursday the government’s decision to ban 344 fixed dose combination drugs.

The Delhi high court scrapped on Thursday a government ban on popular drugs such as Corex, Saridon and Vicks Action 500 and called it a haphazard decision, underlining the uncertainties that dog India’s large but under-regulated medical sector.

Popular drugs like Vicks Action 500 may soon be back in store shelves.
Popular drugs like Vicks Action 500 may soon be back in store shelves.

Many of these drugs went off the market after the health ministry banned 344 fixed-dose combination drugs in March but were back on shop shelves after pharma companies obtained a judicial stay on the order.

Hindustan Times - your fastest source for breaking news! Read now.

With justice RS Endlaw’s verdict on Thursday, these drugs – including D’Cold, Benadryl and Phensedyl that are widely used to treat headaches and colds – will continue be available freely in the market.

Highlights

Popular drugs such as Benadryl may soon be back, with the Delhi high court scrapping the government’s decision to ban 344 fixed dose combination drugs

The health ministry had banned these fixed-dose combination medicines in March over fears that they cause anti-microbial resistance and might even cause organ-failure because of high toxicity

Read | FDC drugs banned keeping safety in mind: Govt tells Delhi HC

The court said proceedings before the ban didn’t suggest “there was any grave urgency”.

Fixed-dose combination drugs, or FDCs, combine two or more drugs in a single pill and are widely used to improve patient compliance as it is easier to get someone to take one drug than several.

The health ministry had banned these fixed-dose combination medicines over fears that they cause anti-microbial resistance and might even cause organ-failure because of high toxicity.

India is one of the world’s largest markets for fixed dose combination drugs that make up almost half the market share but medical experts say most of them are irrational, that is they haven’t been approved by the national regulator.

Read | Banning irrational drugs is good, just mind the process

Many of them slip through India’s labyrinthine regulation process with agencies at the central and state level, which often don’t coordinate.

A total of 453 petitions separate petitions were filed by pharma companies challenging the validity of the Centre’s ban.

The Centre had defended its decision saying these medicines are potential health and safety hazards. It said the ban impacting over 6,000-odd brands was aimed at curbing the misuse of medicines.

The companies, on the other hand, had contended that no enquiry was made from them or show cause notice issued prior to the notification. They said drug in the same combination is being marketed in other countries also.

(with agency inputs)

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On